Literature DB >> 15693318

Amniotic membrane transplantation for reconstruction of corneal epithelial surface in cases of partial limbal stem cell deficiency.

Virender S Sangwan1, Himanshu P Matalia, Geeta K Vemuganti, Gullapalli N Rao.   

Abstract

PURPOSE: To assess the efficacy of amniotic membrane for treatment of partial limbal stem cell deficiency (LSCD).
METHODS: Medical records of four patients with partial LSCD who underwent pannus resection and amniotic membrane transplantation (AMT) were reviewed for ocular surface stability and improvement in visual acuity. Clinico-histopathological correlation was done with the resected pannus tissue.
RESULTS: All the eyes exhibited stable corneal epithelial surface by an average of 7 weeks postoperatively with improvement in subjective symptoms. Best corrected visual acuity improved from preoperative (range: 6/9p-6/120) to postoperative (range: 6/6p-6/15) by an average of 4.5 lines on Snellen visual acuity charts. Histopathological examination of excised tissue showed features of conjunctivalisation.
CONCLUSION: Amniotic membrane transplantation appears to be an effective means of reconstructing the corneal epithelial surface and for visual rehabilitation of patients with partial limbal stem cell deficiency. It may be considered as an alternative primary procedure to limbal transplantation in these cases.

Entities:  

Mesh:

Year:  2004        PMID: 15693318

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  13 in total

Review 1.  Niche regulation of corneal epithelial stem cells at the limbus.

Authors:  Wei Li; Yasutaka Hayashida; Ying-Ting Chen; Scheffer C G Tseng
Journal:  Cell Res       Date:  2007-01       Impact factor: 25.617

2.  The fate of limbal epithelial progenitor cells during explant culture on intact amniotic membrane.

Authors:  Wei Li; Yasutaka Hayashida; Hua He; Ching-Liang Kuo; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

3.  Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  Ahmad Kheirkhah; Victoria Casas; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Am J Ophthalmol       Date:  2008-03-10       Impact factor: 5.258

4.  Vernal keratoconjunctivitis: culmination of management using immunosuppression, surgical and prosthetic therapy over quarter century.

Authors:  Shilpa Das; Anand S Pasari; Virender S Sangwan
Journal:  BMJ Case Rep       Date:  2016-11-23

5.  Update on amniotic membrane transplantation.

Authors:  Jingbo Liu; Hosam Sheha; Yao Fu; Lingyi Liang; Scheffer Cg Tseng
Journal:  Expert Rev Ophthalmol       Date:  2010-10

6.  Gene expression profile of epithelial cells and mesenchymal cells derived from limbal explant culture.

Authors:  Naresh Polisetti; Prasoon Agarwal; Imran Khan; Paturu Kondaiah; Virender S Sangwan; Geeta K Vemuganti
Journal:  Mol Vis       Date:  2010-07-06       Impact factor: 2.367

7.  Minimal conjunctival limbal autograft for total limbal stem cell deficiency.

Authors:  Ahmad Kheirkhah; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Cornea       Date:  2008-07       Impact factor: 2.651

8.  Comparative analysis of fresh and dry preserved amniotic membrane transplantation in partial limbal stem cell deficiency.

Authors:  Joginder Pal Chugh; Prachi Jain; Rajeev Sen
Journal:  Int Ophthalmol       Date:  2014-06-05       Impact factor: 2.031

9.  Tissue remodeling after ocular surface reconstruction with denuded amniotic membrane.

Authors:  Jing Jie; Jie Yang; Hui He; Jianlan Zheng; Wenyan Wang; Liying Zhang; Zhiyuan Li; Jingyao Chen; M Vimalin Jeyalatha; Nuo Dong; Huping Wu; Zuguo Liu; Wei Li
Journal:  Sci Rep       Date:  2018-04-23       Impact factor: 4.379

10.  Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency.

Authors:  Namrata Sharma; Sujata Mohanty; Vishal Jhanji; Rasik B Vajpayee
Journal:  Clin Ophthalmol       Date:  2018-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.